PubRank

Jacques Tostain

Author PubWeight™ 74.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005 3.15
2 Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004 3.06
3 Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 2009 2.41
4 Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol 2008 2.37
5 Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol 2007 2.30
6 Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2006 2.15
7 Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer 2005 2.15
8 Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 2007 2.09
9 Prognostic value of thrombocytosis in renal cell carcinoma. J Urol 2006 1.87
10 Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol 2011 1.87
11 Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma. J Urol 2009 1.83
12 A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol 2008 1.77
13 Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol 2007 1.67
14 Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 2004 1.52
15 Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol 2007 1.51
16 C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 2007 1.43
17 Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol 2006 1.27
18 Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int 2007 1.19
19 Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 2007 1.11
20 Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol 2007 1.08
21 Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol 2007 1.06
22 Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol 2008 1.05
23 Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. Can Urol Assoc J 2008 1.03
24 Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol 2009 1.02
25 Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004 0.98
26 Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int 2007 0.98
27 Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. Eur Urol 2007 0.98
28 Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database. Urology 2005 0.97
29 Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy. Cancer 2008 0.94
30 A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. J Urol 2007 0.92
31 Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol 2009 0.89
32 Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. Eur Urol 2010 0.89
33 Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma. BJU Int 2008 0.89
34 Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol 2004 0.88
35 Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer 2005 0.88
36 Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy. BJU Int 2009 0.87
37 Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 2006 0.87
38 [Complications and medium-term functional results of TVT in stress urinary incontinence]. Prog Urol 2003 0.86
39 [Varicocele and male infertility: AFU 2006 guidelines]. Prog Urol 2007 0.86
40 Elevated serum-circulating RNA in patients with conventional renal cell cancer. Anticancer Res 2008 0.85
41 Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors. Cell Oncol 2005 0.85
42 CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Urol Oncol 2010 0.85
43 Testosterone Deficiency Syndrome (TDS) needs to be named appropriately--the importance of accurate terminology. Eur Urol 2006 0.85
44 Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer 2007 0.85
45 Tissue compartment analysis for biomarker discovery by gene expression profiling. PLoS One 2009 0.85
46 Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics. Urology 2009 0.84
47 Prognostic variables to predict cancer-related death in incidental renal tumours. BJU Int 2008 0.84
48 Testicular sperm extraction in a single cancerous testicle in patients with azoospermia: a case report. Fertil Steril 2007 0.84
49 ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival. Eur J Cancer 2007 0.84
50 Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int 2008 0.83
51 Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 2005 0.82
52 The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur Urol 2005 0.82
53 Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma. Histol Histopathol 2013 0.82
54 Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells. Anticancer Res 2005 0.81
55 Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram. BJU Int 2007 0.81
56 CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy. Clin Exp Metastasis 2007 0.81
57 Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma. BJU Int 2008 0.81
58 Characteristics of image-detected solid renal masses: implication for optimal treatment. Int J Urol 2004 0.80
59 Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma. Clin Cancer Res 2003 0.78
60 [Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects]. Prog Urol 2003 0.78
61 [Comparison of open and laparoscopic partial nephrectomy: a French multicentre experience]. Prog Urol 2007 0.78
62 Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy. Anticancer Res 2012 0.78
63 [Management of positive margins after total prostatectomy for localized prostate cancer]. Prog Urol 2006 0.78
64 Significance of inhibin B and anti-Müllerian hormone in seminal plasma: a preliminary study. Fertil Steril 2007 0.77
65 The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma. In Vivo 2002 0.77
66 [Design of a prototype operating seat with SESAM (Ergonomic System of Mobile Forearm Rests) mobile armrests designed to optimize the surgeon's ergonomy during pelvic laparoscopy]. Prog Urol 2004 0.75
67 MN/CA9 as a novel molecular marker for the detection of cancer. Expert Opin Med Diagn 2007 0.75
68 [Laparoscopic treatment of an isolated ureteropelvic junction disruption following blunt abdominal trauma]. Prog Urol 2006 0.75
69 First clinical experience in urologic surgery with a novel robotic lightweight laparoscope holder. J Endourol 2013 0.75
70 CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours. Histopathology 2009 0.75
71 [Prognostic factors of invasive bladder cancer with lymph node invasion]. Prog Urol 2002 0.75
72 Transversal European survey on testosterone deficiency diagnosis. Aging Male 2012 0.75
73 Combination of core biopsy and fine-needle aspiration increases diagnostic rate for small solid renal tumors. Anticancer Res 2012 0.75
74 [One-stage laparoscopic bilateral upper pole nephrectomy for ectopic insertion of complete ureteral duplication]. Prog Urol 2003 0.75
75 [Retroperitoneal laparoscopic pyeloplasty: retrospective study of 45 consecutive adult cases]. Prog Urol 2006 0.75